Skip to main content
Caplight Logo









Lixa

Lixa

Private
NedlandsHealthcare & Life Scienceshttps://www.lixa.life/

Last Round

VC Round

Jun 5, 2025

Total Funding Raised

$1.53M

Company Overview

Lixa is a biotechnology company that develops small-molecule resistance modulators designed to dismantle bacterial biofilms and restore the effectiveness of existing antimicrobial treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

antimicrobial resistanceAMRantibiofilmbacterial biofilmdrug discoverysuperbugbiotechnologysmall moleculeAI drug discoveryclinical trialbiocidemicrobial contaminationpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lixa Comparables

Compare Lixa with similar companies based on industry and business-model similarity.

Lixa comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Disperazol Pharma ApS
79%
BioTryp Therapeutics
78%
Microbion Corporation
74%

Lixa Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 5, 2025
GrantAug 16, 2024
SeedSep 1, 2022

Key People

Founding team and executive leadership

Kristen Cubbage

Chief Operating Officer

Executive Team

Lixa Investors

Notable investors and investment history

Lixa investors
InvestorRounds
New Industries and Innovation FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 681% MoM.

  • Dec 26, 2025

    Grew 23% QoQ, from 13 to 16 employees.

Lixa Filings

Explore SEC and related filing metadata, where available.

Lixa filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lixa's valuation, stock price, and market status.

Is Lixa a public or private company?

Lixa is a private company.

What is the current stock price of Lixa?

Lixa is a private company with no public stock price. No recent secondary market data is available.

How much is Lixa worth (valuation)?

Valuation information for Lixa is not publicly available.

Can I buy Lixa stock?

Lixa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lixa's last funding round?

Lixa's most recent funding round was VC Round on June 5, 2025.

Who are the main investors in Lixa?

Key investors in Lixa include New Industries and Innovation Fund.

Will Lixa IPO soon?

No public IPO plans have been announced for Lixa.

How can I track Lixa secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lixa's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNedlands
Employee Range13
Year Founded2021
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?